NCT06060223Completed
Teach Back Method in Individuals With Heart Failure
The Effect of Teach Back Method on Symptom Control, Treatment Compliance and Self-Care Behaviors in Individuals With Heart Failure
Source: ClinicalTrials.gov · Last updated 15 Feb 2024
Brief summary (registry, in English)
This study will be conducted to determine the effect of the training given to indivuduals with heart failure by teach back method on their symptom control, adherence to treatment and self care behaviours.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 62 (actual)
- First submitted
- 23 Sept 2023
- Start date
- 3 Oct 2022
- Primary completion date
- 14 Feb 2024
- Lead sponsor
- Amasya University
- Diseases
- Heart failure
- NCT number
- NCT06060223
What you commit to
- Study type: Interventional
- Participants enrolled: 62
- From 3 Oct 2022 to the primary completion date, 14 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Those with neuro-psychiatric disease
Age
- under 18 years old
Other
- Patients with cognitive dysfunction
- Those who did not consent to participate in the research
Who the study is looking for
- Individuals diagnosed with heart failure at least 6 months ago
- Individuals who speak and understand Turkish
- Able to communicate by phone
- İndividuals who can read and write
- Those who gave consent to participate in the research
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Amasya University Coordinator of this site? Confirm its status | Merkez | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.